Lisa Goldfeder
About Lisa Goldfeder
Lisa Goldfeder is a Regulatory Affairs Scientist at the National Institutes of Health, where she has worked since 2017. She holds a Bachelor of Science in Microbiology from the University of New Hampshire and previously served as a Clinical Protocol Coordinator at the same institution from 2011 to 2017.
Work at National Institutes of Health
Lisa Goldfeder has been employed at the National Institutes of Health (NIH) since 2017, serving as a Regulatory Affairs Scientist. In this role, she is involved in ensuring compliance with regulatory standards and guidelines within the organization. Prior to her current position, she worked at NIH as a Clinical Protocol Coordinator from 2011 to 2017. Her experience at NIH spans over a decade, contributing to various projects and initiatives in the field of regulatory affairs and clinical research.
Education and Expertise
Lisa Goldfeder earned a Bachelor of Science degree in Microbiology from the University of New Hampshire, where she studied from 1992 to 1997. This educational background provides her with a strong foundation in microbiological principles, which is relevant to her work in regulatory affairs. Her expertise encompasses both the scientific and regulatory aspects of clinical research, allowing her to effectively navigate the complexities of compliance and protocol management.
Background
Lisa Goldfeder has a professional background that includes significant experience in regulatory affairs and clinical research. Her tenure at the National Institutes of Health has allowed her to develop a comprehensive understanding of the regulatory landscape in biomedical research. This background supports her role in overseeing clinical protocols and ensuring adherence to regulatory requirements.
Career Progression
Lisa Goldfeder's career at the National Institutes of Health reflects a progression from Clinical Protocol Coordinator to Regulatory Affairs Scientist. This advancement demonstrates her growth and increasing responsibilities within the organization. Her work has involved critical aspects of clinical research, including protocol development and regulatory compliance, highlighting her commitment to the field.